Discover how REAC (Radio Electric Asymmetric Conveyer) technology helps the body regulate itself through endogenous bioelectric modulation. Watch the intro video.

When we hear about REAC technology (Radio Electric Asymmetric Conveyer), the first thing to understand is that it is not a traditional therapy designed to act exclusively on a specific symptom or target an isolated organ.
It is something profoundly different. REAC technology works on the way our body organizes and regulates itself. To truly understand it, we need a shift in perspective: do not focus solely on the problem, but observe how the entire biological system responds and adapts to that problem.
Simply put, REAC is a cutting-edge technology designed to help the body function better—making it more coherent, stable, and efficient. It does not introduce foreign substances into the body, does not force any biological process, and does not replace other clinical treatments. Instead, it intervenes on a much more subtle and fundamental level: the internal communication of the organism.
The vast majority of treatments we know follow a very specific logic: there is a deficit, and it is compensated for; there is a symptom, and the goal is to reduce or silence it. REAC technology follows a completely different scientific philosophy.
REAC does not compensate. On the contrary, it works on the system’s natural ability to regulate itself. It is like helping a large orchestra regain its synchronization and the right rhythm, rather than artificially turning up the volume of a single out-of-tune instrument.
Every single function of our body depends on precise signals: electrical, neurofunctional, and adaptive. When this dense internal communication network becomes disorganized—due to stress, trauma, aging, or pathologies—the body begins to struggle and can no longer respond effectively to external and internal challenges.
REAC technology acts by promoting the reorganization of these processes without imposing an artificial direction. As highlighted by the extensive scientific literature produced by researchers Rinaldi and Fontani, REAC acts through endogenous bioelectric modulation, positively influencing metabolic signaling pathways at the cellular level and promoting functional brain reorganization in response to chronic stress or neurobiological alterations. The system is gently guided toward a more natural and functional response.
Every clinical field and every patient present unique specificities. For this reason, REAC technology does not use a “standard” one-size-fits-all approach but relies on different protocols, each structured to optimize specific systems or functions. Recent research demonstrates, for example, the application of Neuro Postural Optimization (NPO) protocols to promote postural and motor symmetry, Neuromotor Optimization (NMO) protocols for functional recovery, and specific protocols for neurodevelopment.
None of these protocols act directly in a suppressive manner on the pathology, but rather intervene exactly on the neuro-adaptive mechanisms that generated it. And this is exactly where the substantial difference compared to conventional therapies lies.
To have a clear picture, it is worth emphasizing what this technology is not:
It is, rather, a technology that supports natural adaptation processes, helping the human body self-regulate in a much more effective and long-lasting way.
Ultimately, the principle behind REAC technology is as simple as it is fascinating: it never asks the body to do something new or foreign to its nature. It simply helps it do better what it already knows how to do perfectly since birth.
Dr. Vania Fontani MD, PhD, is a prominent figure in the field of regenerative medicine and neurobiological modulation.
She has dedicated her career to research and the development of innovative technologies for human well-being.
Currently, Dr. Fontani holds the position of Scientific Director at the Rinaldi Fontani Institute in Florence, where she leads the Department of Regenerative Medicine.
In collaboration with Prof. Salvatore Rinaldi, she co-developed the REAC® (Radio Electric Asymmetric Conveyer) technology, a non-invasive methodology aimed at modulating endogenous bioelectric activity to promote health and well-being.
Her research work is documented in over 60 scientific publications, with a significant impact in the field of neuromodulation and regenerative medicine.
Her experience and expertise make her an ideal speaker for international events focused on innovation and longevity
Learn more:
• Publications: PubMed – Rinaldi S, Fontani V
Physician and researcher, pioneer in neurobiological modulation, regenerative medicine, and anti-senescence therapies Scientific Director – Rinaldi Fontani Institute, Florence, Italy
ORCID: 0000-0002-8961-6316
Profile and Mission
Salvatore Rinaldi is an internationally recognized innovator for his groundbreaking
contribution to the study and clinical application of neurobiological modulation using
asymmetrically conveyed radio-electric signals (REAC). His work has redefined the
boundaries of regenerative medicine and longevity, demonstrating how optimizing
endogenous bioelectrical activity can promote cellular reprogramming, recovery of
compromised functions, and the prevention of age-related decline.
Research Milestones
Rinaldi’s research has opened new frontiers in the understanding and treatment of
neurodegenerative diseases and cellular aging processes. Among his most significant
contributions:
Regenerative Medicine:
Anti-Senescence and Longevity:
Neurodegenerative Diseases – Efficacy of REAC Technology in Alzheimer’s and
Neurodegeneration Models:
Scientific Vision
Salvatore Rinaldi’s work demonstrates that bioelectrical modulation is not merely a
theoretical concept, but a concrete and reproducible therapeutic strategy to counteract
aging, support cellular repair processes, and prevent tissue degeneration.
Learn more:
• ORCID Profile: 0000-0002-8961-6316
• Publications: PubMed – Rinaldi S, Fontani V